Regulus Therapeutics Inc. (RGLS): Price and Financial Metrics
RGLS Price/Volume Stats
| Current price | $1.40 | 52-week high | $3.79 |
| Prev. close | $1.42 | 52-week low | $1.08 |
| Day low | $1.39 | Volume | 151,500 |
| Day high | $1.44 | Avg. volume | 1,236,807 |
| 50-day MA | $1.54 | Dividend yield | N/A |
| 200-day MA | $1.88 | Market Cap | 91.70M |
RGLS Stock Price Chart Interactive Chart >
Regulus Therapeutics Inc. (RGLS) Company Bio
Regulus Therapeutics is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. The company was founded in 2007 and is based in San Diego, California.
RGLS Price Returns
| 1-mo | -6.04% |
| 3-mo | -20.90% |
| 6-mo | -30.69% |
| 1-year | 7.69% |
| 3-year | -60.89% |
| 5-year | -79.72% |
| YTD | 9.37% |
| 2023 | -6.57% |
| 2022 | -56.51% |
| 2021 | -76.67% |
| 2020 | 51.69% |
| 2019 | -4.30% |
Continue Researching RGLS
Here are a few links from around the web to help you further your research on Regulus Therapeutics Inc's stock as an investment opportunity:Regulus Therapeutics Inc (RGLS) Stock Price | Nasdaq
Regulus Therapeutics Inc (RGLS) Stock Quote, History and News - Yahoo Finance
Regulus Therapeutics Inc (RGLS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...